Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 597

[135] Carelli V, Di Colo G, Guerrini C, Nannipieri E. Drug release from silicone elastomer
through controlled polymer cracking: an extension to macromolecular drugs. Int J Pharm
1989;50:181-8.
[136] Hoth M, Merkle HP. Formulation of silicone matrix systems for long-term constant
release of peptides. Drug Dev Ind Pharm 1991;17:985-99.
[137] Banga AK, Chien YW. Systemic delivery of therapeutic peptides and proteins. Int J
Pharm 1988;48:15-50.
[138] Heller J. Polymers for controlled parenteral delivery of peptides and proteins. Adv Drug
Delivery Rev 1993;10:163-204.
[139] Edelman ER, Brown L, Langer R. Quantification of insulin release from implantable
polymer-based delivery systems and augmentation of therapeutic effect with simultane-
ous release of somatostatin. J Pharm Sci 1996;85:1271-5.
[140] Sato N, Okada T, Horiuchi H, Murakami N, Takakashi J, Nawata M, et al. A biodegrad-
able polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol
2001;19:332-5.
[141] Izhar U, Schwalb H, Borman JB, Hellener GR, Hotoveli-Salomon A, Marom G, et al.
Novel synthetic selectively degradable vascular prostheses: a preliminary implantation
study. J Surg Res 2001;95:152-60.
[142] Mukherjee B, Santra K, Pattnaik G, Ghosh S. Preparation, characterization and in-vitro
evaluation of sustained release protein-loaded nanoparticles based on biodegradable
polymers. Int J Nanomedicine 2008;3:487-96.
[143] Ravikumar M, Kumar N. Polymeric controlled drug delivery systems: perspective
issues and opportunities. Drug Dev Ind Pharm 2001;27:1-30.
[144] Mishra N, Goyal AK, Khatri K, Vaidya B, Paliwal R, Rai S, et al. Biodegradable
polymer based particulate carrier(s) for the delivery of proteins and peptides. Anti-
Inflammatory Anti-Allergy Agents Med Chem 2008;7:240-51.
[145] Lewis DH. Controlled release of bioactive agents from lactide/glycolide polymers. In:
Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems, drugs
and pharmaceutical sciences, vol. 45. New York, NY: Marcel Dekker; 1990. p. 1-8.
[146] Lewis DH. Controlled release of bioactive agents from lactide/glycolide polymers. In:
Chasin M, Langer R, editors. Biodegradable polymers as drug delivery systems, drugs and
pharmaceutical sciences, vol. 45. New York, NY: Marcel Dekker; 1990. p. 9-41.
[147] Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control
Release 2003;90:261-80.
[148] Jain RA. The manufacturing techniques of various drug loaded biodegradable
poly(lactide- co -glycolide) devices. Biomaterials 2000;21:2475-90.
[149] Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to
cells and tissue. Adv Drug Delivery Rev 2003;55:329-47.
[150] Holland SJ, Tighe BJ, Gould PL. Polymers for biodegradable medical devices. 1. The
potential of polyesters as controlled macromolecular release systems. J Control Release
1986;4:155-80.
[151] Mehta RC, Jeyanthi R, Calis S, Thanoo BC, Burton KW, DeLuca PP. Biodegradable
microspheres as depot system for parenteral delivery of peptide drugs. J Control Release
1994;29:375-84.
[152] Burns SA, Hard R, Hicks WL Jr., Bright FV, Cohan D, Sigurdson L, et al. Determining
the protein drug release characteristics and cell adhesion to a PLLA or PLGA biode-
gradable polymer membrane. J Biomed Mater Res, Part A 2010;94A:27-37.
[153] Gehrke SH, Uhden LH, McBride JF. Enhanced loading and activity retention of bioac-
tive proteins in hydrogel delivery systems. J Control Release 1998;55:21-33.